Veru VERU
NASDAQ VERU
$2.64 +0.06 (+2.33%)
At close: Aug 21, 2026 · 4:00 PM EDT

Veru (VERU) Net Equity Issued and Repurchased (2018 - 2025)

Veru (VERU) posted quarterly Net Equity Issued and Repurchased of $23.4 million for Q4 2025, down 30.39% quarter-over-quarter from $33.6 million in Q2 2024.

Veru (VERU) Net Equity Issued and Repurchased (2018 - 2025) Analysis & Trends

Veru (VERU) has reported Net Equity Issued and Repurchased for 7 consecutive years, with $23.4 million the latest figure, recorded in Q4 2025.

  • In Q4 2025, Net Equity Issued and Repurchased changed N/A year-over-year to $23.4 million; the TTM figure through Mar 2026 stood at $23.4 million (down 30.39% YoY), while the FY2024 annual figure was $35.2 million, up 608.96% from the prior year.
  • Net Equity Issued and Repurchased retreated to $23.4 million in Q4 2025 per VERU's latest filing, from $33.6 million in the prior quarter.
  • Across five years, Net Equity Issued and Repurchased topped out at $33.6 million in Q2 2024 and bottomed at -$8.4 million in Q2 2021.
  • Historically, Net Equity Issued and Repurchased has averaged $8.2 million across 4 years, with a median of $5.0 million in 2023.
  • Annual changes were most pronounced in 2021 — Net Equity Issued and Repurchased slumped 268.0% — and 2024, when it surged 1405.32%.
  • Veru's Net Equity Issued and Repurchased stood at -$8.4 million in 2021, then soared by 119.78% to $1.7 million in 2023, then jumped by 1920.3% to $33.6 million in 2024, then sank by 30.39% to $23.4 million in 2025.
  • Business Quant data shows VERU's Net Equity Issued and Repurchased at $23.4 million in Q4 2025, $33.6 million in Q2 2024, and $1.7 million in Q4 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 49.20 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn -
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Veru 60.85 Mn 35.06 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2025 23.37 Mn
Dec 31, 2025 23.37 Mn
Jun 30, 2024 33.57 Mn
Jun 30, 2024 33.57 Mn
Dec 31, 2023 1.66 Mn
Dec 31, 2023 1.66 Mn
Sep 30, 2023 4.97 Mn
Sep 30, 2023 4.97 Mn
Jun 30, 2023 -2.57 Mn
Jun 30, 2023 -2.57 Mn
Jun 30, 2021 -8.40 Mn
Jun 30, 2021 -8.40 Mn
Mar 31, 2021 5.00 Mn
Mar 31, 2021 5.00 Mn
Jun 30, 2020 5.00 Mn
Jun 30, 2020 5.00 Mn
Jun 30, 2019 3.60 Mn
Jun 30, 2019 3.60 Mn
Mar 31, 2019 9.13 Mn
Mar 31, 2019 9.13 Mn